- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT02175628
Comparison of the Sensitivity and Specificity of Acoustic Angiography to the Sensitivity and Specificity of Conventional Ultrasound
Comparison of the Sensitivity and Specificity of Acoustic Angiography (Micro-tumor Detection by Quantifying Tumor-induced Vascular Abnormalities) to the Sensitivity and Specificity of Conventional Ultrasound
Purpose: This study will evaluate a new ultrasound imaging technology called acoustic angiography. Acoustic angiography uses an ultrasound contrast agent, already FDA approved for use in cardiology, to enhance imaging of blood vessels. Since acoustic angiography uses ultrasound, and not x-rays, the patient is not exposed to ionizing radiation, unlike traditional angiography and mammography. Specific goals will be to evaluate the quality of the images provided by acoustic angiography in the human breast, and furthermore to evaluate whether or not acoustic angiography provides additional diagnostic information over traditional ultrasound which could provide an improvement in assessing breast lesions. Specifically, this additional diagnostic information will hopefully enable us to reduce false positive tests and discriminate lethal cancers from non-lethal disease.
Participants: The investigators are recruiting 60 patients from the UNC Breast Clinic who are undergoing core needle biopsy or surgical biopsy (BIRADS 4 and 5 breast lesions).
Procedures (methods): Acoustic Angiography imaging will be performed in conjunction with standard diagnostic imaging, including b-mode ultrasound . Then, a reader study will be conducted to compare these modalities. Finally, the images will be analyzed with image processing techniques to determine quantitative metrics exhibited by the blood vessel morphology in the images. These metrics will be utilized to develop a "malignancy score" equation to predict malignancy of a lesion.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Increasing the sensitivity and specificity of diagnostic imaging in patients at high risk for breast cancer could provide substantial clinical benefit by improving diagnosis, preventing over-treatment, and reducing healthcare costs. Acoustic angiography is a new type of contrast enhanced ultrasound imaging which is specifically sensitive to microvascular structure and density. It evaluates tumor micro-vasculature and may provide a powerful prognostic tool for the diagnosis of breast cancer, and eventually for treatment evaluation.
Sixty patients who are to have a clinical surgical breast biopsy based on results from pre-study standard of care (SOC) imaging will be recruited from the UNC Breast Clinic for participation in the study. The primary objective of this single arm study is to compare the sensitivity and specificity of acoustic angiography with traditional b-mode ultrasound in the distinction of malignant versus benign breast lesions. Secondary objectives include a comparison of area under the curve (AUC) for acoustic angiography versus b-mode ultrasound, comparison of radiologist preference for the two imaging techniques for each of 3 lesion characteristics, and quantification of vessel tortuosity based on acoustic angiography imaging results. These metrics will be used to develop a predictive model of malignancy which will subsequently be compared to results from radiology review.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
North Carolina
-
Chapel Hill, North Carolina, Vereinigte Staaten, 27599
- UNC Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Women ≥18 years old
- Scheduled for breast core needle or surgical biopsy of at least one breast lesion based on suspicious breast lesion (BIRADS score of 4 or 5) from pre-study SOC imaging studies
- Center of suspicious lesion is not deeper than 1.5 cm, and the diameter of the lesion is not greater than 2 cm
- Able to provide informed consent
- Negative urine pregnancy test in women of child-bearing potential
Exclusion Criteria:
- Male (it is uncommon for men to present for imaging and the overwhelming majority of findings are non-cancerous and do not lead to biopsy; male breast cancer represents <1% of newly diagnosed breast cancer)
- Institutionalized subject (prisoner or nursing home patient)
- Critically ill or medically unstable and whose critical course during the observation period would be unpredictable (e.g., chronic obstructive pulmonary disease (COPD)
- Known hypersensitivity to sulfur hexafluoride or to any component of perflutren lipid (Definity®)
- Right to left shunt, severe pulmonary hypertension (pulmonary artery pressure >90mmHg), or adult respiratory distress syndrome
Active cardiac disease including any of the following:
- Severe congestive heart failure (class IV in accordance with the classification of the New York Heart Association)
- Unstable angina.
- Severe arrhythmia (i.e. ventricular tachycardia, flutter fibrillation; ventricular premature complexes occurring close to the preceding T-wave, multifocal complexes).
- Myocardial infarction within 14 days prior to the date of proposed Definity® administration.
- Uncontrolled systemic hypertension (systolic blood pressure (BP) >150 mm Hg and/or diastolic BP >90 mm Hg despite optimal medical management
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Diagnose
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Acoustic Angiography
All breast patients will be included in the experimental group.
|
Acoustic angiography imaging involves a research high frequency ultrasound scanner (VisualSonics Vevo 770) and a prototype transducer as well as conventional b-mode ultrasound to guide the location of the imaging. The conventional ultrasound will be conducted just prior to the acoustic angiography for localization. The imaging also requires administration of Definity ultrasound contrast agent. Acoustic angiography imaging will be performed by trained medical personnel using mild compression to eliminate motion. Total imaging time is estimated to be less than 15 minutes. All image data will be de-identified and transferred for off-line analysis based on a study ID. The research images will NOT be interpreted or analyzed for clinical decisions related to the patient. |
Experimental: Healthy Volunteers
A volunteer group was added to the study to perfect the image acquisition techniques.
|
Acoustic angiography imaging involves a research high frequency ultrasound scanner (VisualSonics Vevo 770) and a prototype transducer as well as conventional b-mode ultrasound to guide the location of the imaging. The conventional ultrasound will be conducted just prior to the acoustic angiography for localization. The imaging also requires administration of Definity ultrasound contrast agent. Acoustic angiography imaging will be performed by trained medical personnel using mild compression to eliminate motion. Total imaging time is estimated to be less than 15 minutes. All image data will be de-identified and transferred for off-line analysis based on a study ID. The research images will NOT be interpreted or analyzed for clinical decisions related to the patient. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Sensitivity and Specificity (Percentage)
Zeitfenster: 1.5 years
|
To compare (using a reader study) the sensitivity and specificity of acoustic angiography to the sensitivity and specificity of conventional b-mode ultrasound in evaluation of breast lesions
|
1.5 years
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Area Under the Curve (AUC) of Acoustic Angiography
Zeitfenster: 1.5 years
|
The AUC of acoustic angiography compared to the AUC of b-mode ultrasound
|
1.5 years
|
Radiologist Preference
Zeitfenster: 1.5 years
|
To compare radiologist preference of acoustic angiography to conventional b-mode ultrasound for each lesion characteristic (shape, margins and vascularity)
|
1.5 years
|
Vessel Tortuosity (No Units)
Zeitfenster: 1.5 years
|
To quantify vessel tortuosity metrics for the acoustic angiograph images, and to use these metrics to develop a model for predicting malignancy (a model-based malignancy score)
|
1.5 years
|
Model-based Malignancy Score (Arbitrary Units)
Zeitfenster: 1.5 years
|
To compare the model-based malignancy score to the acoustic angiography reader study
|
1.5 years
|
Mitarbeiter und Ermittler
Mitarbeiter
Ermittler
- Hauptermittler: Yueh Lee, MD, PhD, University of North Carolina, Chapel Hill
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- LCCC1405
- R01CA170665 (US NIH Stipendium/Vertrag)
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Anzeichen und Symptome
-
Abramson Cancer Center at Penn MedicineAktiv, nicht rekrutierendAdolescent and Young Adult (AYA) KrebsüberlebendeVereinigte Staaten
-
Mundipharma Research LimitedBeendetACOS (Fixed Airflow Obstruction and Elevated Eosinophils)Slowakei
-
University Medical Center GroningenMartini Hospital GroningenAbgeschlossen
-
Fundación SenefroBaxter Healthcare CorporationUnbekanntHämodialyse-induziertes SymptomSpanien
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityNoch keine RekrutierungUreterstent-bezogenes Symptom
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... und andere MitarbeiterAbgeschlossenGewalt, häusliche | Gewaltbezogenes SymptomVereinigte Staaten
-
Benha UniversityNew Jeddah Clinic HospitalAbgeschlossenHämodialyse-induziertes Symptom
-
National Taiwan University HospitalAbgeschlossenZusammenhang zwischen hämodynamischer Veränderung und während der Hämodialyse entfernter FlüssigkeitHämodialyse-Komplikation | Hämodialyse-induziertes SymptomTaiwan
-
Instituto Nacional de Ciencias Medicas y Nutricion...AbgeschlossenEinhaltung der Diät (Symptom)
-
Mersin UniversityAbgeschlossen
Klinische Studien zur Acoustic Angiography
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RekrutierungPlaque der Halsschlagader | Karotisstenose | Plaque, ArterioskleroseVereinigte Staaten
-
SolitonAbgeschlossenZellulitisVereinigte Staaten
-
SolitonEmergent Clinical Consulting, LLCAbgeschlossen
-
Children's Hospital Medical Center, CincinnatiSiemens Medical SolutionsAbgeschlossen
-
SolitonUnited States Naval Medical Center, San DiegoNoch keine RekrutierungNarben, hypertroph
-
Johann Wolfgang Goethe University HospitalAbgeschlossenChronische Hepatitis CNiederlande, Deutschland, Frankreich
-
Hemolens Diagnostics Sp. z o.o.GENELYTICA Sp. z o.o.RekrutierungKoronare Herzkrankheit | Stabile ischämische HerzkrankheitPolen
-
Nottingham University Hospitals NHS TrustUniversity of Nottingham; University College, LondonAbgeschlossen
-
University of MichiganChildren's Hospital Medical Center, CincinnatiAbgeschlossenLeberfibroseVereinigte Staaten
-
Applaud Medical, Inc.Aktiv, nicht rekrutierendHarnsteineVereinigte Staaten